Sakalihasan N., Limet R., and Defawe O.D. Abdominal aortic aneurysm. Lancet 365 (2005) 1577-1589
Limet R., Sakalihasan N., and Albert A. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms. J Vasc Surg 14 (1991) 540-548
McMillan W.D., and Pearce W.H. Inflammation and cytokine signaling in aneurysms. Ann Vasc Surg 11 (1997) 540-547
Newman K.M., Jean-Claude J., Li H., Scholes J.V., Ogata Y., Nagase H., et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 20 (1994) 814-820
Thompson R.W., Holmes D.R., Mertens R.A., Liao S., Botney M.D., Mecham R.P., et al. Production and localization of 92 kilodalton gelatinase in abdominal aortic aneurysms and elastolytic metalloproteinase expressed by aneurysm infiltrating macrophages. J Clin Invest 96 (1995) 318-326
Sakalihasan N., Delvenne Ph, Nusgens B., Limet R., and Lapière C.M. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24 (1996) 127-133
Sakalihasan N., Heyères A., Nusgens B.V., Limet R., and Lapière C.M. Modification of the extracellular matrix of aneurysmal abdominal aortas as a function of their size. Eur J Vasc Surg 7 (1993) 633-637
Baxter B.T., McGee G.S., Shively V.P., Drummond I.A., Dixit S.N., Yamauchi M., et al. Elastin content, cross-links, and mRNA in normal and aneurysmal human aorta. J Vasc Surg 16 (1992) 192-200
Defawe O.D., Colige A., Lambert C.A., Munaut C., Delvenne P., Lapière C.M., et al. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Res 60 (2003) 205-213
Defawe O.D., Colige A., Lambert C.A., Delvenne P., Lapière ChM, Limet R., et al. Gradient of proteolytic enzymes, their inhibitors and matrix proteins expression in a ruptured abdominal aortic aneurysms. Eur J Clin Invest 34 (2004) 513-514
Knox J.B., Sukhova G.K., Whittemore A.D., and Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95 (1997) 205-212
Lindholt J.S., Vammen S., Fasting H., Henneberg E.W., and Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 24 (2000) 281-285
Petersen E., Gineitis A., and Wagberg F. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture. Eur J Vasc Endovasc Surg 20 (2000) 457-461
Larson S.M. Positron Emission Tomography in oncology and allied diseases. In: Devita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancers, principles and practice of oncology. 2nd Ed 3 (1999), JB Lippincott Publishing, Philadelphia 1-12
Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., and Ido T. Intratumoral distribution of fluorin-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiographic comparison with FDG. J Nucl Med 33 (1992) 1872-1880
Vallabhajosula S., Machac J., Knesaurek K., et al. Imaging atherosclerotic macrophage density by Positron Emission Tomography using 18-fluorodeoxyglycose (FDG). J Nucl Med (1996) 37-38
Hunter G.C., Smyth S.H., Aguirre M.L., Baxter B.T., Bull D.A., King D.D., et al. Incidence and histologic characteristics of blebs in patients with abdominal aortic aneurysms. J Vasc Surg 24 (1996) 93-101
Warburg O., Wind F., and Neglers E. In: Warburg O. (Ed). Metabolism of tumors (1930), Constable, London 254
Hustinx R., Bénard F., and Alavi A. Whole-body imaging in the management of patients with cancer. Semin Nucl Med 32 (2002) 35-46
Strauss L.G. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23 (1996) 1409-1415
Heelan B.T., Osman S., Blyth A., Schnorr L., Jones T., and George A.J. Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography. Transplantation 66 (1998) 1101-1103
Yamada S., Kubota K., Kubota R., Ido T., and Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36 (1995) 1301-1306
Ishimori T., Saga T., Mamede M., Kobayashi H., Higashi T., Nakamoto Y., et al. Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 43 (2002) 658-663
Sugawara Y., Gutowski T.D., Fisher S.J., Brown R.S., and Wahl R.L. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med 26 (1999) 333-341
Scharko A.M., Perlman S.B., and Hinds P.W. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci USA 93 (1996) 6425-6430
Zhuang H., and Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32 (2002) 47-59
Belhocine T., Blockmans D., Hustinx R., Vandevivere J., and Mortelmans L. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 30 (2003) 1305-1313
Yun M., Jang S., Cucchiara A., Newberg A.B., and Alavi A. 18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 32 (2002) 70-76
Yun M., Yeh D., Araujo L.I., Jang S., Newberg A., and Alavi A. F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med 26 (2001) 314-319
Rudd J.H., Warburton E.A., Fryer T.D., Jones H.A., Clark J.C., Antoun N., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
Sakalihasan N., Hustinx R., and Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Sem Vasc Surg 17 (2004) 144-153
Defawe O.D., Hustinx R., Defraigne J.O., Limet R., and Sakalihasan N. Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med 30 (2005) 340-341
UK Small Aneurysm Trial Participants. Health cost and quality of life for early elective surgery or ultrasonography surveillance for small abdominal aortic aneurysms. Lancet 1998; 352:1656-60.
Sterpetti A.V., Cavallaro A., Cavallari N., Allegrucci P., Tamburelli A., Agosta F., et al. Factors influencing the rupture of abdominal aortic aneurysms. Surg Gyn & Obst 173 (1991) 175-178
Glimaker H., Hollmberg L., Elvin A., Nybacka O., Almgren B., Björck C.G., et al. Natural history of patients with abdominal aortic aneurysm. Eur J Vasc Surg 5 (1991) 125-130
